2nd Annual CARE Congress: Update on Biosimilars and Access to Innovation

This year’s meeting seeks to address questions and considerations regarding biosimilars in Canada and how they build towards a larger discussion on access to innovative medicine. This meeting will include discussion and will provide a platform for medical specialists and key stakeholders across multiple fields to meet, collaborate, and discuss concepts that have a practical impact on the Canadian healthcare landscape.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is:
2nd Annual CARE Congress: Update on Biosimilars and Access to Innovation